WeedMD and BLOCKStrain launch the first validation and traceability of blockchain based cannabis

Canada has made history the first country to completely legalize marijuana, which was already an innovative decision to get started. Now, this policy has allowed many companies to thrive, even if the validation of product authenticity has been largely unregulated and unlicensed. WeedMD, a group of cannabis native to Ontario, has officially obtained its license as a producer able to authenticate and track the varieties of cannabis, which is now part of the sales program. While this prowess is remarkable by itself, it is also the first company in the world to do so.

The license allowed WeedMD to create a "first of its kind" cannabis validation registration program, which was done in collaboration with Blockstrain Technology Corp. CEO of WeedMDKeith Merker commented: "We congratulate all the teams that have worked on this exceptional achievement: with the completion of genetic testing, consumers will appreciate the traceability and assurance of the origin of the WeedMD cannabis that are buying. "He added:" We now have a total of 40 active cannabis strains from our genetic bank that hold the Blockstrain Certificate of Authenticity and are able to be crossed as verifiable strains in the Blockstrain database, from the genome to the sale. "

Blockstrain's CEO, Robert Galarza, is also optimistic about what this new program and this new license bring to its brand. In favor of what the partnership brings to the table for consumers, Galarza said:

"For years, consumers have purchased cannabis-based products with very little information on exactly what is purchased, but now they can trace the origin of the strain and their CBD and / or THC content, along with other relevant information Thanks to the exclusive technology of the Genome Strain Master and the Clone Registration Program, manufacturers can now secure their strains and provide customers with the certainty of the product. "

During this program, the Blockstrain team takes on the role of collecting data from implants and performing protocols for genomic sequencing. The results are recorded in the database, performed on the blockchain, which protects the intellectual property from being altered and validates the strains that have been examined. All information collected during this period can be monitored by anyone involved with the company.